Browse > Article

A Case of MPO-ANCA Positive Vasculitis Associated with Pulmonary Nodules and Membranous Nephropathy Following Propylthiouracil Treatment  

Ryu, Kwang-Duck (Department of Internal Medicine, Pusan National University School of Medicine)
Bae, Min-Jung (Department of Internal Medicine, Pusan National University School of Medicine)
Baek, Dong-Hoon (Department of Internal Medicine, Pusan National University School of Medicine)
Shin, Min-Ji (Department of Internal Medicine, Pusan National University School of Medicine)
Seong, Eun-Young (Department of Internal Medicine, Pusan National University School of Medicine)
Song, Sang-Heon (Department of Internal Medicine, Pusan National University School of Medicine)
Kwak, Ihm-Soo (Department of Internal Medicine, Pusan National University School of Medicine)
Publication Information
The Korean Journal of Medicine / v.81, no.3, 2011 , pp. 397-402 More about this Journal
Abstract
Vasculitis is one of the rare complications of antithyroid drugs. In most cases, it is associated with ANCA and usually involves more than one organ. Renal involvement is the most common manifestation, and mainly presents as pauci-immune glomerulonephritis. We experienced MPO-ANCA-positive vasculitis and renal involvement presenting as membranous nephropathy following propylthiouracil (PTU) treatment. Cases of MPO-ANCA-positive vasculitis with membranous nephropathy are very uncommon, and the relationship between PTU and glomerulonephritis with immune complex deposition is unclear at present. A 58-year-old woman who had been treated with PTU for Graves' disease was admitted because of dyspnea and general edema. Chest computed tomography showed multiple nodules in both lung fields. The serum level of MPO-ANCA was positive. Initial laboratory findings included proteinuria, hematuria and increased serum creatinine. We thought that MPO-ANCA-associated vasculitis was induced by PTU and renal involvement. Renal biopsy revealed membranous nephropathy.
Keywords
Propylthiouracil; ANCA-associated vasculitis; Pulmonary nodule; Membranous nephropathy;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-418.   DOI   ScienceOn
2 Cooper DS. Antithyroid drugs. N Engl J Med 1984;311:1353-1362.   DOI   ScienceOn
3 Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998;27:109-126.   DOI   ScienceOn
4 Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992;102:1595-1596.   DOI   ScienceOn
5 Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-652.   DOI   ScienceOn
6 Kang AY, Baek YH, Sohn YJ, et al. Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil. Korean J Intern Med 2006;21:240-243.   DOI   ScienceOn
7 Chen YX, Yu HJ, Li LY, et al. Propylthiouracil-associated antineutrophil cytoplasmic autoan tibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 2007;34:2451-2456.
8 Yu F, Chen M, Gao Y, et al. Clinical and pat hological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis 2007;49:607-614.   DOI   ScienceOn
9 Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr J 2002;49:329-334.   DOI   ScienceOn
10 Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophjl cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract 2009;63:299-302.   DOI   ScienceOn
11 Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994;266:810-813.   DOI
12 Von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995;268:585-586.
13 Shimizudani N, Senba S, Odaka T, et al. A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment. Nihon Kokyuki Gakkai Zasshi 2009;47:98-103.
14 Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-784.   DOI   ScienceOn
15 Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol 2002;17:257-260.   DOI   ScienceOn
16 Grcevska L, Polenakovic M, Petrusevska G. Membranous nephropathy associated with thyroid disorders. Nephron 2000;86:534-535.   DOI   ScienceOn
17 Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev 1984;5:309-355.   DOI   ScienceOn
18 Kim HJ, Baek JE, Ha HJ, et al. A case of membranous nephropathy in a patient with Graves' disease. Korean J Med 2003;64:130-136.